Florence Suzan

1.4k total citations
38 papers, 772 citations indexed

About

Florence Suzan is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Florence Suzan has authored 38 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 17 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Florence Suzan's work include Multiple Myeloma Research and Treatments (21 papers), Cancer Treatment and Pharmacology (8 papers) and Protein Degradation and Inhibitors (8 papers). Florence Suzan is often cited by papers focused on Multiple Myeloma Research and Treatments (21 papers), Cancer Treatment and Pharmacology (8 papers) and Protein Degradation and Inhibitors (8 papers). Florence Suzan collaborates with scholars based in France, Switzerland and United Kingdom. Florence Suzan's co-authors include Stéphanie Vandentorren, Mathilde Pascal, Martine Ledrans, Sylvia Médina, Carole Soussain, Khê Hoang‐Xuan, Vincent Lévy, Nathalie Cassoux, Coralie Bélanger and Vincent Ribrag and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Public Health.

In The Last Decade

Florence Suzan

34 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence Suzan France 9 237 228 225 198 193 38 772
Johannes Rischewski Switzerland 22 75 0.3× 48 0.2× 83 0.4× 390 2.0× 50 0.3× 40 1.2k
Susan E. Carozza United States 24 183 0.8× 63 0.3× 130 0.6× 18 0.1× 264 1.4× 46 1.8k
Edoardo Conticini Italy 13 53 0.2× 60 0.3× 84 0.4× 31 0.2× 332 1.7× 82 1.2k
Shui He United States 13 372 1.6× 75 0.3× 749 3.3× 476 2.4× 45 0.2× 38 1.7k
Alain Robert France 24 323 1.4× 201 0.9× 168 0.7× 401 2.0× 75 0.4× 45 1.4k
Marie-Françoise Auclerc France 16 92 0.4× 38 0.2× 95 0.4× 330 1.7× 78 0.4× 37 886
Kenneth Wong United States 17 44 0.2× 83 0.4× 159 0.7× 102 0.5× 83 0.4× 53 829
Suhong Luo United States 15 120 0.5× 15 0.1× 155 0.7× 382 1.9× 35 0.2× 65 899
Sándor Baráth Hungary 13 137 0.6× 19 0.1× 25 0.1× 39 0.2× 237 1.2× 41 823
Jonathan Giovannelli France 16 415 1.8× 65 0.3× 23 0.1× 17 0.1× 171 0.9× 32 855

Countries citing papers authored by Florence Suzan

Since Specialization
Citations

This map shows the geographic impact of Florence Suzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Suzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Suzan more than expected).

Fields of papers citing papers by Florence Suzan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Suzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Suzan. The network helps show where Florence Suzan may publish in the future.

Co-authorship network of co-authors of Florence Suzan

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Suzan. A scholar is included among the top collaborators of Florence Suzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Suzan. Florence Suzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Quach, Hang, Gurdeep Parmar, Enrique M. Ocio, et al.. (2024). A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma. Haematologica. 109(12). 4078–4082. 2 indexed citations
3.
4.
Terpos, Evangelos, Borhane Slama, Renato Zambello, et al.. (2020). Real-World Evidence of the Use of Carfilzomib Among Multiple Myeloma Patients with at Least One Prior Therapy across 10 European Countries and Israel. Blood. 136(Supplement 1). 38–39. 4 indexed citations
5.
6.
Caers, Jo, Xavier Leleu, Barbara Gamberi, et al.. (2019). Real-World Use of Carfilzomib Therapy Among Patients With Existing Cardiovascular Medical History: An Analysis of a Prospective Observational Study. Clinical Lymphoma Myeloma & Leukemia. 19(10). e281–e282.
7.
Despiégel, Nicolas, Alain Flinois, Grèce Saba, et al.. (2018). Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France. Clinical Lymphoma Myeloma & Leukemia. 19(1). e13–e28. 38 indexed citations
8.
Terpos, Evangelos, Florence Suzan, & Hartmut Goldschmidt. (2018). Going the distance: Are we losing patients along the multiple myeloma treatment pathway?. Critical Reviews in Oncology/Hematology. 126. 19–23. 7 indexed citations
9.
Cook, Gordon, Sonja Zweegman, María‐Victoria Mateos, Florence Suzan, & Philippe Moreau. (2017). A question of class: Treatment options for patients with relapsed and/or refractory multiple myeloma. Critical Reviews in Oncology/Hematology. 121. 74–89. 26 indexed citations
10.
Mounier, Morgane, S. Gauthier, Xavier Troussard, et al.. (2016). 5-Year Overall Survival and Progression-Free Survival in Multiple Myeloma by Line of Treatment from the French Hematologic Malignancy Registry. Value in Health. 19(7). A762–A762. 1 indexed citations
11.
Meunier, Sandrine, et al.. (2013). Use of Clinical Practice Guidelines on Long-term Prophylaxis in Severe Hemophilia in France: A Retrospective Audit. The Journal of Pediatrics. 162(6). 1241–1244.e1. 6 indexed citations
12.
Chambost, Hérvè & Florence Suzan. (2010). Épidémiologie des maladies hémorragiques constitutionnelles : apport de la cohorte nationale. Archives de Pédiatrie. 17(6). 618–619. 3 indexed citations
13.
Rogel, A., Aurélien Belot, Florence Suzan, et al.. (2010). Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri. Cancer Epidemiology. 35(3). 243–249. 4 indexed citations
14.
Kremp, O, Florence Suzan, A. Aouba, et al.. (2008). Mortalité liée à la drépanocytose en France de 0 à 18 ans. Archives de Pédiatrie. 15(5). 629–632. 3 indexed citations
15.
Jabbour, Elias, Florence Suzan, Călin Cainap, et al.. (2004). Outcome of Elderly Patients with Aggressive Non-Hodgkin's Lymphoma Refractory to or Relapsing after First-line CHOP or CHOP-like Chemotherapy: A Low Probability of Cure. Leukemia & lymphoma. 45(7). 1391–1394. 15 indexed citations
16.
Vandentorren, Stéphanie, et al.. (2004). Mortality in 13 French Cities During the August 2003 Heat Wave. American Journal of Public Health. 94(9). 1518–1520. 236 indexed citations
17.
Ribrag, Vincent, Florence Suzan, Christophe Ravoet, et al.. (2003). Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts. Leukemia. 17(2). 319–322. 5 indexed citations
18.
Suzan, Florence, Géraldine Guasch, Christine Terré, et al.. (2003). Long‐term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). British Journal of Haematology. 121(2). 312–314. 12 indexed citations
19.
Suzan, Florence, Christine Terré, Jean Bastié, et al.. (2001). Three cases of typical aplastic anaemia associated with a Philadelphia chromosome. British Journal of Haematology. 112(2). 385–387. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Rischewski Breakdown of academic impact, for papers by Susan E. Carozza Breakdown of academic impact, for papers by Edoardo Conticini Breakdown of academic impact, for papers by Shui He Breakdown of academic impact, for papers by Alain Robert Breakdown of academic impact, for papers by Marie-Françoise Auclerc Breakdown of academic impact, for papers by Kenneth Wong Breakdown of academic impact, for papers by Suhong Luo Breakdown of academic impact, for papers by Sándor Baráth Breakdown of academic impact, for papers by Jonathan Giovannelli
Rankless by CCL
2026